We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Connected Health Devices Support Hypertension Management

By HospiMedica International staff writers
Posted on 17 Sep 2018
New premium smart monitors promote better blood pressure (BP) control by allowing users to share data with healthcare providers.

The A&D Medical (San Jose, CA, USA) ULTRACONNECT blood pressure monitors offer a range of features and capabilities, including a sleek, tubeless design that slips easily onto the wrist or arm; a bright organic light-emitting diode (OLED) display that provides illuminated BP feedback to the user; a light-weight, compact design that allows users to transport the device wherever they go, ensuring consistent tracking of blood pressure readings; and multi-user support functionality for up to five regular users plus an anonymous guest.

Users can operate, access data, and share their BP results via Smart Connect, an automatic feature that detects and connects the monitor to the proprietary A&D Connect app, which is designed to enhance the end-user experience with engaging, easy-to-use features such as graphing, trending, unlimited memory, reminders, and goal setting. More...
In addition, an offline, stand-alone setup allows for transfer of up to 100 readings to the A&D Connect app at a later time. A&D Connect offers robust compatibility with both iOS and Android devices.

“The recent change in hypertension guidelines from the AHA underscores the need for more consumers to monitor and understand their own blood pressure readings. That means providing patients with the right tools to make it extremely easy to self-monitor on a regular basis, so they can make changes in their own lives to reduce hypertension-related risks,” said Terry Duesterhoeft, President and CEO of A&D Medical. “The new product line leverages our more than four decades of experience in designing and delivering connected products to both the consumer and healthcare spaces.”

The 2014 AHA BP recommendations, issued by an expert panel appointed to the Eighth Joint National Committee, suggest that for most hypertensive individuals 60 or older, pharmacologic treatment should be started when systolic BP is 150 mm Hg or higher or diastolic BP is 90 mm Hg or higher, with the goal of achieving readings below those cutoffs. For younger patients and for those with chronic kidney disease or diabetes, (regardless of age) treatment should be initiated when systolic BP is 140 or higher or diastolic BP is 90 or higher.

Related Links:
A&D Medical



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.